View of Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer

Return to Article Details Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer Download Download PDF